Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: Preliminary results and survival analysis

Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg, 250, 187, 10.1097/SLA.0b013e3181b13ca2 Sebbag, 2000, Results of treatment of 33 patients with peritoneal mesothelioma, Br J Surg, 87, 1587, 10.1046/j.1365-2168.2000.01571.x Price, 1997, Analysis of current trends in United States mesothelioma incidence, Am J Epidemiol, 145, 211, 10.1093/oxfordjournals.aje.a009093 Acherman, 2003, Clinical presentation of peritoneal mesothelioma, Tumori, 89, 269, 10.1177/030089160308900307 Welch, 2005, Asbestos and peritoneal mesothelioma among college-educated men, Int J Occup Environ Health, 11, 254, 10.1179/oeh.2005.11.3.254 Wagner, 2005, Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province, Br J Ind Med, 17, 260 Yan, 2007, A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma, Ann Oncol, 18, 827, 10.1093/annonc/mdl428 Chahinian, 1982, Diffuse malignant mesothelioma. Prospective evaluation of 69 patients, Ann Intern Med, 96, 746, 10.7326/0003-4819-96-6-746 Riddell, 1981, Peritoneal malignant mesothelioma in a patient with recurrent peritonitis, Cancer, 48, 134, 10.1002/1097-0142(19810701)48:1<134::AID-CNCR2820480124>3.0.CO;2-4 Peterson, 1984, Non-asbestos-related malignant mesothelioma. A review, Cancer, 54, 951, 10.1002/1097-0142(19840901)54:5<951::AID-CNCR2820540536>3.0.CO;2-A Baratti, 2007, Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC), Ann Surg Oncol, 14, 2790, 10.1245/s10434-007-9475-8 Baratti, 2008, Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC), In Vivo, 22, 153 Baratti, 2010, Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), Eur J Surg Oncol, 36, 1047, 10.1016/j.ejso.2010.08.130 Yan, 2009, Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience, J Clin Oncol, 27, 6237, 10.1200/JCO.2009.23.9640 Feldman, 2003, Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy, J Clin Oncol, 21, 4560, 10.1200/JCO.2003.04.150 Passot, 2008, Peritoneal mesothelioma: treatment with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, J Chir Paris, 145, 447 Elias, 2002, Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution, Ann Oncol, 13, 267, 10.1093/annonc/mdf019 Elias, 2004, Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance, Ann Oncol, 15, 1558, 10.1093/annonc/mdh398 Elias, 2007, Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy, Gastroenterol Clin Biol, 31, 784, 10.1016/S0399-8320(07)73964-7 Elias, 2011, Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model, Ann Surg, 254, 138, 10.1097/SLA.0b013e3182193143 Elias, 2004, Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin, Br J Surg, 91, 455, 10.1002/bjs.4399 Elias, 2007, HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin, Cancer Treat Res, 134, 303 Elias, 2009, Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin, J Clin Oncol, 27, 681, 10.1200/JCO.2008.19.7160 Hompes, 2012, The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study, Ann Surg Oncol, 19, 2186, 10.1245/s10434-012-2264-z Mohamed, 2011, A new standard of care for the management of peritoneal surface malignancy, Curr Oncol, e84, 10.3747/co.v18i2.663 Weiss, 1994, World health organization Sugarbaker, 1998, Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis, Semin Surg Oncol, 14, 254, 10.1002/(SICI)1098-2388(199804/05)14:3<254::AID-SSU10>3.0.CO;2-U Glehen, 2003, Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma, Surg Oncol Clin N Am, 12, 649, 10.1016/S1055-3207(03)00037-1 Sridhar, 1992, New strategies are needed in diffuse malignant mesothelioma, Cancer, 70, 2969, 10.1002/1097-0142(19921215)70:12<2969::AID-CNCR2820701239>3.0.CO;2-A Markman, 1992, Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma, J Cancer Res Clin Oncol, 118, 547, 10.1007/BF01225271 Yates, 1997, Malignant mesothelioma in south east England: clinicopathological experience of 272 cases, Thorax, 52, 507, 10.1136/thx.52.6.507 Neumann, 1999, Peritoneal mesothelioma–incidence and etiology, Pathologe, 20, 169, 10.1007/s002920050340 Eltabbakh, 1999, Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma, J Surg Oncol, 70, 6, 10.1002/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X Elias, 2004, Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Prelim results 24 patients, Ann Oncol, 15, 781, 10.1093/annonc/mdh186 Sugarbaker, 2006, Comprehensive management of diffuse malignant peritoneal mesothelioma, Eur J Surg Oncol, 32, 686, 10.1016/j.ejso.2006.03.012 Mohamed, 2003, Challenging and unusual cases: case 3. Peritoneal cystic mesothelioma, J Clin Oncol, 21, 1419, 10.1200/JCO.2003.06.167 González-Moreno, 2002, Malignant transformation of “benign” cystic mesothelioma of the peritoneum, J Surg Oncol, 79, 243, 10.1002/jso.10081 DeStephano, 1985, Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case, Pediatr Pathol, 4, 291, 10.3109/15513818509026902 Chua, 2011, Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma, Br J Surg, 98, 60, 10.1002/bjs.7263 Brigand, 2006, Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study, Ann Surg Oncol, 13, 405, 10.1245/ASO.2006.05.041